HFA Cardio Talk cover art

All Episodes

HFA Cardio Talk — 52 episodes

#
Title
1

Post myocardial infarction – how to prevent, diagnose, and treat heart failure

2

Valvular heart disease: a new chapter in heart failure management

3

Post myocardial infarction – how to prevent, diagnose, and treat heart failure

4

The evolving landscape in the treatment of amyloidosis

5

Conduction system pacing: the right choice in heart failure?

6

A multidisciplinary team approach to HF

7

Heart failure in adult congenital heart disease patients

8

Inotropes and vasodilators in heart failure

9

The future of trials in heart failure

10

Late-breaking clinical science from ESC Congress 2025

11

Iron in heart failure - case closed?

12

Late Breaking Clinical Trial updates from Heart Failure 2025

13

Management of LVAD in patients with advanced heart failure

14

Inequalities in heart failure: sex, socioeconomic status, and ethnicity

15

Rapid up-titration of GDMT in heart failure

16

Obesity in Heart Failure

17

Invasive Monitoring in Heart Failure

18

Understanding revascularization in heart failure: why, for whom, and when

19

Heart Failure in Pregnancy: Peripartum Cardiomyopathy

20

Controversies in ICD/CRT implantation in non-ischemic cardiomyopathy for primary prevention

21

Heart Failure clinical trials from ESC Congress 2024

22

Worsening Heart Failure: Definition, Management, and Outcomes

23

Natriuresis-Guided Diuresis in Acute Heart Failure

24

Late Breaking Clinical Trial updates from Heart Failure 2024

25

Atrial Fibrillation ablation in Heart Failure patients

26

Future Pathways: Guiding the next generation of heart failure specialists

27

Reversible causes of Heart Failure

28

New perspectives in HF treatment

29

The role of Artificial intelligence in heart failure.

30

The Role of Circulating Biomarkers in Heart Failure

31

Clinical inertia and optimization of heart failure therapy

32

Making sense of clinical trials. A conversation with Stuart Pocock.

33

Heart failure insights from the ESC congress 2023, Amsterdam, the Netherlands

34

Cardiorenal axis and congestion

35

Preventing Heart Failure From Evidence to Action

36

Exploring the journey of Heart Transplantation - where are we in 2023?

37

Insights from late breaking clinical trials from the Heart Failure Congress 2023, Prague, Czech

38

A deep dive into translational science in Heart Failure. Lessons learnt and future perspectives.

39

Shock Talk: Epidemiology, pathophysiology and contemporary management of cardiogenic shock

40

Advanced heart failure: definition, diagnostic work-up, tips and tricks - introduction to the first HFA Advanced Heart Failure course

41

Diagnosis and management of myocarditis: current state and future perspectives

42

Emerging key role of Patients Profiling in Heart Failure patients' management

43

Valvular heart disease in patients with heart failure

44

The changing role of Cardiovascular Magnetic Resonance in Heart Failure patients

45

Lived Experiences of Dyads with a Left Ventricular Assist Device: Lessons Learned for Around the World

46

Gene Editing: Paving the way to end the burden of inherited cardiomyopathies or just a useful research tool?

47

HFpEF – The enigma of Heart Failure

48

Highlights from Heart Failure Congress 2022, Madrid, Spain

49

Tips and tricks in interpretation of clinical trials

50

Implementing the use of HF treatments in clinical practice

51

The SGLT2-inhibitors revolution in Heart Failure. Current indications and future perspectives

52

Medical treatment for heart failure. News and controversies from 2021 ESC heart failure Guidelines